1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Therapy Analysis & Statistics, May 2015 (p50)

Therapy Analysis & Statistics, May 2015 (p50)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

1471-1500 of about 3 000 reports

Purchase Reports From Reputable Market Research Publishers

Anika Therapeutics, Inc. (ANIK) - Financial and Strategic SWOT Analysis Review

Anika Therapeutics, Inc. (ANIK) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2015
  • by Global Data

Anika Therapeutics, Inc. (ANIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : Therapy
  • Countries : United States
Amicus Therapeutics, Inc. (FOLD) - Financial and Strategic SWOT Analysis Review

Amicus Therapeutics, Inc. (FOLD) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2015
  • by Global Data

Amicus Therapeutics, Inc. (FOLD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : Therapy
Cellerant Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cellerant Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2015
  • by Global Data

Summary Cellerant Therapeutics is a pharmaceutical company which develops human stem cell and antibody therapies for oncology applications and blood-related disorders. The company develops stem cell products, ...

  • Industries : Therapy
Osteonecrosis - Pipeline Review, H1 2015

Osteonecrosis - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Osteonecrosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Osteonecrosis - Pipeline Review, H1 2015’, provides an overview of the Osteonecrosis’s therapeutic pipeline. This report ...

  • Industries : Biological Therapy, Pharmaceutical
  • Countries : World
Cytori Therapeutics, Inc. (CYTX) - Product Pipeline Analysis, 2015 Update

Cytori Therapeutics, Inc. (CYTX) - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Company report
  • May 2015
  • by Global Data

Summary Cytori Therapeutics, Inc. (Cytori Therapeutics) is a US-based pharmaceutical company. It undertakes the development of cell therapies based on autologous adipose-derived regenerative cells (ADRCs) ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States
Ischemic Cerebral Stroke - Pipeline Review, H1 2015

Ischemic Cerebral Stroke - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Ischemic Cerebral Stroke - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Ischemic Cerebral Stroke - Pipeline Review, H1 2015’, provides an overview of the Ischemic Cerebral Stroke’s ...

  • Industries : Pathology
  • Countries : United States, World
Binge Eating Disorder - Pipeline Review, H1 2015

Binge Eating Disorder - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Binge Eating Disorder - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Binge Eating Disorder - Pipeline Review, H1 2015’, provides an overview of the Binge Eating Disorder’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, World
United Therapeutics Corporation - Product Pipeline Review - 2015

United Therapeutics Corporation - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • May 2015
  • by Global Markets Direct

United Therapeutics Corporation - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘United Therapeutics Corporation - Product Pipeline Review - 2015’, provides an overview of the ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States
Anaplastic Astrocytoma - Pipeline Review, H1 2015

Anaplastic Astrocytoma - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Anaplastic Astrocytoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Anaplastic Astrocytoma - Pipeline Review, H1 2015’, provides an overview of the Anaplastic Astrocytoma’s therapeutic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Equine Encephalitis - Pipeline Review, H1 2015

Equine Encephalitis - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Equine Encephalitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Equine Encephalitis - Pipeline Review, H1 2015’, provides an overview of the Equine Encephalitis’s therapeutic ...

  • Industries : Biopharmaceutical, Drug and Medication, Biotechnology
  • Countries : Venezuela
Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015’, provides an overview of the Type ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Neurofibromatoses Type II - Pipeline Review, H1 2015

Neurofibromatoses Type II - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Neurofibromatoses Type II - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Neurofibromatoses Type II - Pipeline Review, H1 2015’, provides an overview of the Neurofibromatoses Type II’s ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
BIND Therapeutics, Inc. - Product Pipeline Review - 2015

BIND Therapeutics, Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • May 2015
  • by Global Markets Direct

BIND Therapeutics, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘BIND Therapeutics, Inc. - Product Pipeline Review - 2015’, provides an overview of the BIND Therapeutics, ...

  • Industries : Therapy, Pharmaceutical, Research and Development
  • Countries : United States
ImmunoCellular Therapeutics, Ltd. (IMUC) - Financial and Strategic SWOT Analysis Review

ImmunoCellular Therapeutics, Ltd. (IMUC) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2015
  • by Global Data

ImmunoCellular Therapeutics, Ltd. (IMUC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been ...

  • Industries : Therapy
Corcept Therapeutics Incorporated (CORT) - Financial and Strategic SWOT Analysis Review

Corcept Therapeutics Incorporated (CORT) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2015
  • by Global Data

Corcept Therapeutics Incorporated (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been ...

  • Industries : Therapy
Sarepta Therapeutics, Inc. (SRPT) - Financial and Strategic SWOT Analysis Review

Sarepta Therapeutics, Inc. (SRPT) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2015
  • by Global Data

Sarepta Therapeutics, Inc. (SRPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : Therapy
Celldex Therapeutics, Inc. (CLDX) - Financial and Strategic SWOT Analysis Review

Celldex Therapeutics, Inc. (CLDX) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2015
  • by Global Data

Celldex Therapeutics, Inc. (CLDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : Therapy
  • Countries : United States
Cytori Therapeutics, Inc. (CYTX) - Financial and Strategic SWOT Analysis Review

Cytori Therapeutics, Inc. (CYTX) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2015
  • by Global Data

Cytori Therapeutics, Inc. (CYTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

TG Therapeutics, Inc. (TGTX) - Financial and Strategic SWOT Analysis Review

TG Therapeutics, Inc. (TGTX) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2015
  • by Global Data

TG Therapeutics, Inc. (TGTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : Therapy
Global Prostate Cancer Therapeutics Market to 2020

Global Prostate Cancer Therapeutics Market to 2020

  • $ 1 000
  • Industry report
  • May 2015
  • by Igate Research

Prostate Cancer remains a top priority for health systems around the world as incidence level rises, fueled by growing and aging populations. The main drivers for the prostate cancer market are the increase ...

  • Industries : Pathology, Pharmaceutical, Therapy
  • Countries : World
Global Cardiac Resynchronization Therapy (CRT) Devices Industry 2015 Market Research Report

Global Cardiac Resynchronization Therapy (CRT) Devices Industry 2015 Market Research Report

  • $ 2 850
  • Industry report
  • May 2015
  • by 9Dimen Research

2015 Global Cardiac Resynchronization Therapy (CRT) Devices Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Cardiac Resynchronization ...

  • Industries : Therapy
  • Countries : World, Europe, Asia, North America
Global Melanoma Therapeutics Industry 2015 Market Research Report

Global Melanoma Therapeutics Industry 2015 Market Research Report

  • $ 2 850
  • Industry report
  • May 2015
  • by 9Dimen Research

2015 Global Melanoma Therapeutics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Melanoma Therapeutics industry, focusing on the main ...

  • Industries : Therapy
  • Countries : World, Europe, Asia, North America
PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • May 2015
  • by Global Data

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2023 Summary GlobalData estimates that the total market size for the 8MM in 2013 was $15.4bn, comprised of $11.0bn in branded drug ...

  • Industries : Pharmaceutical, Pathology, Hospitality, Hospitality
  • Countries : World
Pain Therapeutics, Inc. (PTIE) - Financial and Strategic SWOT Analysis Review

Pain Therapeutics, Inc. (PTIE) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2015
  • by Global Data

Pain Therapeutics, Inc. (PTIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : Therapy
Personalised Medicines in Oncology: Assessing Key Drivers and Challenges at the Physician Level (US)

Personalised Medicines in Oncology: Assessing Key Drivers and Challenges at the Physician Level (US)

  • $ 7 370
  • Industry report
  • May 2015
  • by Firstword Pharma

Gain exclusive insights on the perceived value and benefits of personalised medicine and on the key challenges and opportunities in relation to implementation from treating oncologists. Personalised ...

  • Industries : Therapy
Idiopathic Pulmonary Fibrosis: KOL Insight

Idiopathic Pulmonary Fibrosis: KOL Insight

  • $ 7 695
  • Industry report
  • May 2015
  • by Firstword Pharma

Roche’s Esbriet, (pirfenidone) and Boehringer Ingelheim’s Ofev (nintedanib) are the only approved therapies for Idiopathic Pulmonary Fibrosis (IPF). Will either be able to establish themselves as ...

  • Industries : Therapy
  • Countries : United States
Breast Cancer: KOL Insight

Breast Cancer: KOL Insight

  • $ 7 695
  • Industry report
  • May 2015
  • by Firstword Pharma

How will breast cancer be treated in the years ahead – and what targeted therapies represent the greatest potential in terms of transforming disease therapy? KOL Insight: Breast Cancer provides a comprehensive ...

  • Industries : General Medicine and Specialty Medicine, Pathology
  • Countries : United States
Personalised Medicines in Oncology: Assessing Key Drivers and Challenges at the Physician Level (EU5)

Personalised Medicines in Oncology: Assessing Key Drivers and Challenges at the Physician Level (EU5)

  • $ 7 370
  • Industry report
  • May 2015
  • by Firstword Pharma

Gain exclusive insights on the perceived value and benefits of personalised medicine and on the key challenges and opportunities in relation to implementation from treating oncologists. Personalised ...

  • Industries : Therapy
  • Countries : France, Germany, Spain, Italy, Europe
Systemic Psoriasis Therapeutics in Asia-Pacific Markets to 2021 - Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth

Systemic Psoriasis Therapeutics in Asia-Pacific Markets to 2021 - Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth

  • $ 4 995
  • Industry report
  • May 2015
  • by GBI Research

Systemic Psoriasis Therapeutics in Asia-Pacific Markets to 2021 - Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World
PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023 - Event-Driven Update

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023 - Event-Driven Update

  • $ 10 995
  • Industry report
  • May 2015
  • by Global Data

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2023 - Event-Driven Update Summary Alzheimer’s Disease (AD) is a progressive neurodegenerative disease that is characterized ...

  • Industries : Hospitality, Hospitality, Tourism, Tourism
  • Countries : World, Europe, Asia
About 800 reports

Download Unlimited Documents from Trusted Public Sources

Cancer Drug Industry

  • January 2016
    6 pages
  • Cancer Drug  

    Hormone  

    Prostate Cancer  

View report >

Us - Country Risk

December 2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.